Plasminogen Activator Inhibitor Type-1-Deficient Mice Have an Enhanced IFN- Response to Lipopolysaccharide and Staphylococcal Enterotoxin B

Journal of Immunology - United States
doi 10.4049/jimmunol.177.11.8171
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The American Association of Immunologists

Related search

Enhanced Venous Thrombus Resolution in Plasminogen Activator Inhibitor Type-2 Deficient Mice

Journal of Thrombosis and Haemostasis
MedicineHematology
2014English

Metastasis of Transgenic Breast Cancer in Plasminogen Activator Inhibitor-1 Gene-Deficient Mice

Oncogene
Cancer ResearchGeneticsMolecular Biology
2003English

Accessibility of Receptor-Bound Urokinase to Type-1 Plasminogen Activator Inhibitor.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1989English

Human Visceral Adipose Tissue and the Plasminogen Activator Inhibitor Type 1

International Journal of Obesity
NutritionEndocrinologyDieteticsMedicineMetabolismDiabetes
2007English

Interaction of Single-Chain Urokinase and Plasminogen Activator Inhibitor Type 1

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1995English

Oligofructose Decreases Serum Lipopolysaccharide and Plasminogen Activator Inhibitor-1 in Adults With Overweight/Obesity

Obesity
NutritionEndocrinologyDieteticsMedicineMetabolismDiabetes
2017English

Thrombin and Plasmin Generation in Patients With Plasminogen or Plasminogen Activator Inhibitor Type 1 Deficiency

Haemophilia
MedicineGeneticsHematology
2019English

Plasminogen Activator Inhibitor Type 1 Enhances Neointima Formation After Oxidative Vascular Injury in Atherosclerosis-Prone Mice

Circulation
Cardiovascular MedicinePhysiologyCardiology
2001English

Does Plasminogen Activator Inhibitor-1 Drive Lymphangiogenesis?

PLoS ONE
Multidisciplinary
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy